Mod 1 is : Mod 2 is : Mod 3 is : Mod 4 is : Mod 5 is : Mod 6 is :
Alexandria Ratzki-Leewing
PhD (Co-Presenter)
Department of Epidemiology and Biostatistics Schulich School of Medicine and Dentistry, Western University London (ON)
Stewart Harris
CM, MD, MPH, FCFP, FACPM (Chair and Co-Presenter)
Professor Diabetes Canada Chair in
Diabetes Management
Schulich School of Medicine and
Dentistry, Western University
London (ON)
Welcome!
We invite you to engage in this self-learning program composed of bite-sized modules exploring different strategies to effectively manage episodes of severe hypoglycemia.
You can pick and choose, at your own pace, the modules that are of the most interest to you, and therefore, tailor the program to your learning needs.
Stewart Harris, CM, MD, MPH, FCFP, FACPM and Alexandria Ratzki-Leewing, PhD
LEARNING OBJECTIVES
Upon completion of this program, participants will be better able to:
Explain the characteristics, incidence, and risk factors for severe hypoglycemia in people living with type 2 diabetes
Incorporate effective communication strategies with patients and caregivers to minimize the risks and occurrence of severe hypoglycemia
Apply strategies to effectively manage episodes of severe hypoglycemia
CERTIFICATION
This 1-credit-per-hour self-learning activity has been certified by the College of Family Physicians of Canada for up to 1.75 Mainpro+ certified credits. This learning program is brought to you by The CPD Network, a not-for-profit physician organization, with financial support (in the form of an educational grant and in-kind support) from Eli Lilly Canada Inc.
PROGRAM CONTENT
This program can be completed within 30-105 minutes, based on the number of modules you wish to complete.
Mandatory module:
Module 1 must be completed to access the optional modules.
Veuillez vous inscrire ou vous connecter afin d'accéder à ce contenu.
Program Modules
Modules 2-6 will appear locked until Module 1 is completed
Modules 2-6 will appear locked until Module 1 is completed
Module 1
0.5 hours of learning
Module 1
Module 2
0.25 hours of learning
Module 2
Module 3
0.25 hours of learning
Module 2
Module 4
0.25 hours of learning
Module 4
Module 5
0.25 hours of learning
Module 5
Module 6
0.25 hours of learning
Module 6
Additional Resources
As you complete modules, additional resources specific to them will appear below
The Low-Down handout contains practical tips to assess and advise your patients with diabetes about preventing and treating severe hypoglycemia
In cardiovascular disease we strive to prevent recurrent events (like heart attack or stroke) by intervening right after the event. Fractures are "bone attacks". Let’s have the same intention and attention to our patient’s bones to prevent “bone attacks”.
This resource is intended to help achieve that goal. Take a tour to see what these expert physicians are doing in that regard. You will gain some clinical pearls and tools to help you to help your patients towards the goal of no more fractures.
Available tools:
Click on the resource you would like to learn more about and we hope you can use this information to create your own EMR stamp or flow sheet
Please register or login in order to access this content
Expert Steering Committee
Planning Committee Member
Disclosures
Jonathan D Adachi, MD, FRCPC The Actavis Chair in Rheumatology for Better Bone Health Professor, Department of Medicine Michael G. DeGroote School of Medicine St. Joseph’s Healthcare McMaster University Hamilton, ON
Dr. Adachi received research funding, honoraria, and travel grants from, as well as served on advisory boards and had consulting roles for Acativs, AgNovos, Amgen, Eli Lilly, Merck, and Radius.
Algis V. Jovaisas, MD FRCPC Rheumatology Adjunct Professor of Medicine Department of Medicine Faculty of Medicine University of Ottawa Ottawa ON
Dr. Jovaisas received research funding, honoraria, and travel grants from, as well as served on advisory boards and had consulting roles for Alexion, Amgen, Celltrion, Eli Lilly, Gilead, Novartis, Pfizer, Sandoz, and Sanofi-Genzyme.
Jodie M. Reis BHK, MD, FRCPC Rheumatology Associates of Saskatoon Physician lead – Saskatoon Fracture Liaison Service (FLS) Associate Program Director, CBD lead Rheumatology, University of Saskatchewan Assistant Professor, University of Saskatchewan Saskatoon, SK
Dr. Reis received research funding, honoraria, and travel grants from, as well as served on advisory boards and had consulting roles for Amgen, Hospira, Janssen, Lilly, Novartis, Pfizer, Roche, Sanofi, and UCB.
This non-accredited learning activity is financially supported by Amgen Canada and is for healthcare professionals only. This content was developed in concert with the scientific planning committee members and is based on current clinical practice guidelines or expert consensus.
locked until Module 1 is completed
Module 1
